Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

2.

p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.

Kanik AB, Yaar M, Bhawan J.

J Cutan Pathol. 1996 Jun;23(3):205-10.

PMID:
8793654
3.

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Am J Dermatopathol. 2001 Jun;23(3):185-9.

PMID:
11391097
4.

P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.

Lazova R, Tantcheva-Poor I, Sigal AC.

J Am Acad Dermatol. 2010 Nov;63(5):852-8. doi: 10.1016/j.jaad.2009.11.688.

PMID:
20950740
5.

Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.

Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M.

Am J Surg Pathol. 2001 Feb;25(2):205-11.

PMID:
11176069
6.

HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.

Zubovits J, Buzney E, Yu L, Duncan LM.

Hum Pathol. 2004 Feb;35(2):217-23.

PMID:
14991540
7.

KBA.62: a useful marker for primary and metastatic melanomas.

Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.

Hum Pathol. 2008 Aug;39(8):1136-42. doi: 10.1016/j.humpath.2007.12.006. Epub 2008 May 20.

PMID:
18495211
8.

HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.

Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, Liu BY, Sun A, Chiang CP.

J Oral Pathol Med. 2005 Oct;34(9):540-5.

PMID:
16138892
9.

Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.

Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu X.

Am J Dermatopathol. 2004 Dec;26(6):452-7.

PMID:
15618925
10.
11.

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.

Dorvault CC, Weilbaecher KN, Yee H, Fisher DE, Chiriboga LA, Xu Y, Chhieng DC.

Cancer. 2001 Oct 25;93(5):337-43.

PMID:
11668469
12.

Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.

Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Jones EW.

Am J Dermatopathol. 1994 Feb;16(1):14-22.

PMID:
7512798
13.

NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.

Otaibi S, Jukic DM, Drogowski L, Bhawan J, Radfar A.

Am J Dermatopathol. 2011 Feb;33(1):65-71. doi: 10.1097/DAD.0b013e3181dfcb9f.

PMID:
21178583
16.

Immunohistochemical characteristics of melanoma.

Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.

J Cutan Pathol. 2008 May;35(5):433-44. doi: 10.1111/j.1600-0560.2007.00891.x. Review.

PMID:
18399807
17.

Acral lentiginous melanoma: an immunohistochemical study of 20 cases.

Kim YC, Lee MG, Choe SW, Lee MC, Chung HG, Cho SH.

Int J Dermatol. 2003 Feb;42(2):123-9.

PMID:
12709000
18.

Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.

Longacre TA, Egbert BM, Rouse RV.

Am J Surg Pathol. 1996 Dec;20(12):1489-500.

PMID:
8944042
19.

S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.

Argenyi ZB, Cain C, Bromley C, Nguyen AV, Abraham AA, Kerschmann R, LeBoit PE.

Am J Dermatopathol. 1994 Jun;16(3):233-40.

PMID:
7943629
20.

SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.

Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS.

J Cutan Pathol. 2010 Sep;37(9):944-52. doi: 10.1111/j.1600-0560.2010.01568.x.

PMID:
20653825

Supplemental Content

Support Center